Nobel Hygiene Ltd., a homegrown manufacturer of absorbent hygiene products, backed by Quadria Capital. Nobel Hygiene Ltd. has filed the draft document with the market regulator SEBI for raising funds through an IPO. The public offer proposed is a combination of a fresh issue of shares and an Offer-for-Sale.

Breakdown of the Offer-for-Sale and expansion strategy

The structure of the IPO as detailed in the preliminary prospectus issued on Thursday involves a fresh issue of equity shares worth up to ₹150 crore. In parallel with this primary sale, the capital raise also includes an Offer-for-Sale (OFS) of up to 1.55 crore equity shares. The secondary transaction segment will enable the current shareholders or promoters of the company and other early investors to sell a portion of their shares in the company.

The Offer-for-Sale feature of the public issue is a mechanism for key shareholders to sell or reduce their holdings in Nobel Hygiene Ltd. Kamal Kumar Johari and Kamini Kamal Johari are among the promoter group dealing with the sale of shares via an OFS. Their investment in the equity sale underscores a progressive approach towards reducing promoter holdings and incorporating the company into a listed corporate structure.

In addition to the promoter group, several major institutional and venture investors are participating in the secondary sales of the initial public offer. The entities that have been identified in the prospectus filing include Orbit Investment Holdings and Sixth Sense India Opportunities III, and Bennett Trading LLP. These institutional supporters, along with the main promoter group, will also be selling an equity stake in the maximum total allotment of 1.35 crore equity shares.

Nobel Hygiene Ltd has been clear in its financial course with capital raised through the fresh issue of up to ₹150 crore. One of the main goals of using the proceeds is to pay down existing debt, which is expected to lower the company’s overall debt-to-equity ratio and enhance its financial position. Strategic capital deployment will be made through investment in its corporate subsidiary, ‘Nobel Hygiene Baroda Pvt Ltd.’, a portion of the capital.

The capital deployment strategy also involves a significant commitment of resources towards the expansion of manufacturing infrastructure at Halol in Gujarat. The industrial development involves establishing a specific manufacturing and warehousing block to enable efficient operation. 

The company plans to use this production capacity expansion to equip a brand-new adult diaper manufacturing line. The proceeds of the fresh issuance shall be used for general corporate purposes related to ongoing operations and growth efforts, to the extent funds remain after covering the costs of the issuance.

Financial growth performance and operational footprint

Nobel Hygiene Ltd is a major domestic brand in the absorbent hygiene market with an extensive portfolio of personal care products. The company’s brand structure provides for three consumer verticals: Adult Hygiene, Baby Care and Feminine Hygiene Products. It has strong commercial brand labels such as Friends, Teddyy, B-Fit, Snuggy and RIO that support its market presence.

The company operates an extensive inventory management system and large manufacturing capabilities to support its commercial operation. By March 31, 2026, Nobel Hygiene had reached a stage with a large product portfolio of more than 1150 stock keeping units (SKUs). 

Its manufacturing footprint comprises 14 operational production lines, operating from two manufacturing units in Nashik, Maharashtra, and Halol in Gujarat. These facilities collectively have a capacity to produce nearly 1,891 million units per year. Nobel Hygiene Ltd is marketing a wide range of hygiene products and has established a robust commercial distribution network throughout the country. 

The distribution network covers close to 2.7 lakh retail outlets across 31 states and Union Territories. This vast market penetration is made possible by a supply chain network of close to 300 stockists and over 400 specialized distributors. Internationally, the company maintains its presence in neighboring countries by exporting its products to 19 countries in the world.

In FY2026, revenue from operations increased by 14.6% to ₹846.75 crore. The revenue from operations was ₹739.14 crore in FY2025. The profit of the company stood at ₹18.91 crore. The profit of the company was ₹2.28 crore during the previous fiscal year.

Nobel Hygiene Ltd has appointed prominent financial institution advisors to assist in the regulatory, compliance, and underwriting procedures surrounding the upcoming float on the capital market. The book-running lead managers, associated with the public offer structure, institutional book building, and compliance, include ICICI Securities, Motilal Oswal Investment Advisors, and SBI Capital Markets.

Conclusion

The draft prospectus submitted to SEBI denotes that Nobel Hygiene’s business is moving toward the Public Company format and is scaling up production in India. The company will use the fresh investment to reduce debt and build new manufacturing facilities in Gujarat to consolidate its market position in the adult, baby, and women’s health care segments.

With an extensive distribution network in 31 states and a significant export business, the proposed IPO will be a structured pathway for realignment of promoters and participation of institutional investors and will help fund the long-term corporate infrastructure of the company.